Skip to main content

Grafa News and Videos — Page 1272

Latest

Grafa

Sensei Biotherapeutics net loss deepens to $170.2M on Faeth acquisition charges

Sensei Biotherapeutics (NASDAQ:SNSE) reported a significantly wider net loss for the first quarter of 2026, primarily driven by massive, one-time accounting charges stemming from its transformational acquisition of Faeth Therapeutics Inc. earlier in the year.

Read more: Sensei Biotherapeutics net loss deepens to $170.2M on Faeth acquisition charges

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift